Itau Unibanco Holding S.A. Dexcom Inc Transaction History

Itau Unibanco Holding S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $271 - $531	4 Added 133.33%	7 $1,000
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $282 - $390	3 New	3 $2,000
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $20,129 - $25,237	-155 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $5,762 - $7,731	54 Added 53.47%	155 $85,000
Q2 2021 Aug 17, 2021	BUY	$80.99 - $107.93 $8,179 - $10,900	101 New	101 $43,000

1,019

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $32.6B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.